Metraipolis › archive › dc_209c475445e6

Selective Degradation and Inhibition of SARS-CoV-2 3CLpro by MMP14 Reveals a Novel Strategy for COVID-19 Therapeutics — Europe PMC PMID:41096670

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41096670
DOI
10.3390/ijms26199401
License (as archived)
solo-consultazione
Archived
2026-11-09T18:09:51.018Z
SHA-256 of the archived text
3e9520611884ced208f2d310d669af608b0f36505aac134fff02572c52ccf07c
Stable URL of this page
https://metraipolis.com/documento/dc_209c475445e6

How to cite

Selective Degradation and Inhibition of SARS-CoV-2 3CLpro by MMP14 Reveals a Novel Strategy for COVID-19 Therapeutics — Europe PMC PMID:41096670 — Europe PMC (en), https://europepmc.org/article/MED/41096670 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_209c475445e6 (Metraipolis archive dc_209c475445e6, sha256 3e9520611884ced208f2d310d669af608b0f36505aac134fff02572c52ccf07c)
BibTeX
@misc{dc209c475445e6,
  title = {Selective Degradation and Inhibition of SARS-CoV-2 3CLpro by MMP14 Reveals a Novel Strategy for COVID-19 Therapeutics — Europe PMC PMID:41096670},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41096670},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_209c475445e6; sha256 3e9520611884ced208f2d310d669af608b0f36505aac134fff02572c52ccf07c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41096670. Agents can read the archived copy with the MCP tool read_document.